医疗保险责任照护组织:泌尿肿瘤手术后的急性期后照护使用与术后结局
该纵向分析比较2011—2017年医疗保险索赔数据中,524家医疗保险责任照护组织(ACO)医院与2066家非ACO医院的334514例膀胱癌、前列腺癌、肾癌手术患者。膀胱癌手术中ACO参与与急性期后照护使用显著降低相关,但再入院或并发症率无变化;前列腺癌和肾癌手术中无显著关联。
要点
- 膀胱癌手术:ACO参与与总体急性期后照护使用显著降低相关,再入院或并发症率无变化。
- 前列腺癌和肾癌手术:ACO参与与急性期后照护使用或术后结局无显著关联。
- 作者结论:MSSP ACO参与降低膀胱癌手术患者急性期后照护使用而不损害结局。
核心结论
- 医院参与MSSP ACO使接受膀胱癌手术的医疗保险受益人急性期后照护使用降低,且不损害患者结局。
- 未来需要研究以了解ACO参与对泌尿肿瘤手术结局的长期影响。
研究设计与样本
- 对2011—2017年医疗保险索赔数据进行纵向分析,比较MSSP实施前后ACO与非ACO患者的术后结局。
- 研究样本共334514例接受膀胱癌、前列腺癌、肾癌手术的医疗保险患者,来自524家医疗保险ACO医院和2066家非ACO医院。
主要发现
- 膀胱癌手术:ACO参与与总体急性期后照护使用显著降低相关,但与再入院或并发症率变化无关。
- 前列腺癌和肾癌手术:医院参与ACO与急性期后照护使用或术后结局无显著关联。
关键数值与推荐
- 结局指标包括急性期后照护使用(总体、机构型和家庭健康)、熟练护理机构住院时长及熟练护理机构患者的医疗保险支出、指数手术后30天和90天非计划再入院和并发症。
临床怎么用
- 原文未据此给出推荐。
局限性
- 未来需要研究以了解ACO参与对泌尿肿瘤手术结局的长期影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate association between Medicare accountable care organizations (ACOs) participation of hospitals on post-acute care (PAC) use and spending, and post-surgical outcomes in Medicare beneficiaries undergoing urologic cancer surgeries. Despite increasing prevalence of urologic cancer and surgical care contributing to a large proportion of total health care costs, and recent Medicare payment reforms such as accountable care organizations, the role of ACOs in urologic cancer care has been unexplored. METHODS: We conducted a longitudinal analysis of 2011-2017 Medicare claims data to compare post-surgical outcomes between Medicare ACO and non-ACO patients before and after implementation of Medicare shared savings program (MSSP). Our outcomes of interest were Post-acute care (PAC) use (overall, institutional, and home health), Skilled Nursing Facility (SNF) length of stay and Medicare spending for SNF patients, 30-day and 90-day unplanned readmissions and complications after index procedure. RESULTS: Study sample included a total of 334,514 Medicare patients undergoing bladder, prostate, kidney cancer surgeries at 524 Medicare ACO and 2066 non-ACO hospitals. For bladder cancer surgery, Medicare ACO participation was associated with significantly reduced overall post-acute care use, but not with changes in readmission or complication rate. For prostate cancer and kidney cancer surgery, we found no significant association between hospital participation in Medicare ACOs and PAC use or post-surgical outcomes. CONCLUSION: Hospital participation in MSSP ACOs leads to lower post-acute care use without compromising patient outcomes for Medicare beneficiaries undergoing bladder cancer surgery. Future research is needed to understand longer-term impact of ACO participation on urologic cancer surgery outcomes.
引用
- Katragadda C, Fung C, Yousefi-Nooraie R, et al. Medicare Accountable Care Organizations: Post-acute Care Use and Post-surgical Outcomes in Urologic Cancer Surgery. Urology. 2022. PMID: 35772480. doi:10.1016/j.urology.2022.06.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。